<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0002406"><a href="http://purl.obolibrary.org/obo/MONDO_0002406">MONDO:0002406</a></h3>
<p><strong>Label:</strong> dermatitis</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0015104">MONDO:0015104</a> (porphyria cutanea tarda), <a href="http://purl.obolibrary.org/obo/MONDO_0004980">MONDO:0004980</a> (atopic eczema), <a href="http://purl.obolibrary.org/obo/MONDO_0008296">MONDO:0008296</a> (familial porphyria cutanea tarda), <a href="http://purl.obolibrary.org/obo/MONDO_0000136">MONDO:0000136</a> (keratosis follicularis spinulosa decalvans), <a href="http://purl.obolibrary.org/obo/MONDO_0008219">MONDO:0008219</a> (pemphigus vulgaris),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_176090">OMIM:176090</a>, <a href="http://www.orpha.net/ORDO/Orphanet_443062">Orphanet:443062</a>, <a href="http://purl.obolibrary.org/obo/OMIM_308800">OMIM:308800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_101330">Orphanet:101330</a>, <a href="http://purl.obolibrary.org/obo/OMIM_147050">OMIM:147050</a>, <a href="http://purl.obolibrary.org/obo/OMIM_605803">OMIM:605803</a>, <a href="http://purl.obolibrary.org/obo/OMIM_176100">OMIM:176100</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2340">Orphanet:2340</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612843">OMIM:612843</a>, <a href="http://www.orpha.net/ORDO/Orphanet_704">Orphanet:704</a>, <a href="http://purl.obolibrary.org/obo/OMIM_169610">OMIM:169610</a>, <a href="http://purl.obolibrary.org/obo/OMIM_603165">OMIM:603165</a>, <a href="http://purl.obolibrary.org/obo/OMIM_604093">OMIM:604093</a>, <a href="http://www.orpha.net/ORDO/Orphanet_95159">Orphanet:95159</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li>Thing 42.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 42.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001574">HP:0001574</a> (Abnormality of the integument) 40.25%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 38.32%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0011123">HP:0011123</a> (Inflammatory abnormality of the skin) 36.65%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology))) 36.11%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010783">HP:0010783</a> (Erythema) and <a href="http://purl.obolibrary.org/obo/HP_0011123">HP:0011123</a> (Inflammatory abnormality of the skin) 35.61%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 34.57%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 33.74%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 31.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 31.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) 31.46%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) 25.06%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000152">HP:0000152</a> (Abnormality of head or neck) 24.52%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system) 21.30%</li>
</ul>
</body>
</html>
